8-K: Owens & Minor Appoints COO, Restructures HR Leadership
Management Change
Owens & Minor announced the appointment of Perry A. Bernocchi as Chief Operating Officer and the departure of its Chief Human Resources Officer, with HR oversight shifting to the General Counsel.
Summary
- Perry A. Bernocchi has been appointed Executive Vice President, Chief Operating Officer, effective December 5, 2025.
- Mr. Bernocchi, age 67, previously served as Executive Vice President and Chief Executive Officer of the Company's Patient Direct segment since March 2023.
- His compensation and the terms of his employment with the Company remain unchanged.
- Jennifer Stone, Executive Vice President, Chief Human Resources Officer, will leave the Company effective December 31, 2025.
- Upon Ms. Stone's departure, the Chief Human Resources Officer position will be eliminated.
- Heath Galloway, Executive Vice President, General Counsel & Corporate Secretary, will add oversight of the human resources function to his current responsibilities.
Sentiment
Score: 6
Explanation: The filing reports routine executive changes, including a promotion and a departure with a functional reorganization. While the departure of a CHRO could be seen as a minor negative, the promotion of an internal executive to COO and the consolidation of HR under the General Counsel suggest a strategic, albeit neutral to slightly positive, move towards operational efficiency and continuity. No significant positive or negative financial implications are immediately apparent.
Positives
- Appointment of an experienced internal executive, Perry A. Bernocchi, to the critical role of Chief Operating Officer, suggesting continuity and leveraging existing talent.
- Streamlining of executive functions by eliminating the CHRO position and consolidating HR oversight under the General Counsel, potentially improving operational efficiency and reducing overhead.
Negatives
- Departure of a key executive, Jennifer Stone, the Chief Human Resources Officer, which could lead to a temporary disruption in HR leadership.
- Elimination of the dedicated CHRO role, potentially signaling a shift in the strategic emphasis or structure of the human resources function.
Future Outlook
NA
Industry Context
The healthcare distribution and medical supplies industry often sees strategic executive appointments and organizational restructuring to optimize operations and respond to market dynamics. The appointment of an internal COO suggests a focus on operational continuity and leveraging existing leadership, while the HR restructuring could reflect efforts to streamline corporate functions in a competitive environment.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice President, Chief Operating Officer | NA | Perry A. Bernocchi | December 5, 2025 | Appointment to new role, previously EVP and CEO of Patient Direct segment. |
| Executive Vice President, Chief Human Resources Officer | Jennifer Stone | NA | December 31, 2025 | Departure from the Company; position eliminated. |
| Executive Vice President, General Counsel & Corporate Secretary (with added HR oversight) | NA | Heath Galloway | December 31, 2025 | Assumed additional responsibilities for human resources function. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Organizational Restructuring | Elimination of the Chief Human Resources Officer position and consolidation of human resources oversight under the Executive Vice President, General Counsel & Corporate Secretary. | December 31, 2025 | Potentially streamlines executive leadership and integrates HR functions more closely with legal and corporate governance, aiming for efficiency. |
Stakeholder Impact
- Shareholders: May view the changes as a move towards operational efficiency and continuity with an internal COO, potentially stabilizing leadership.
- Employees: The departure of the CHRO and elimination of the role, along with the shift of HR oversight, could lead to uncertainty or changes in HR policies and support structures.
- Customers/Suppliers: Unlikely to be directly impacted by these internal executive and organizational changes in the short term.
Key Dates
| Date | Description |
|---|---|
| March 2023 | Perry A. Bernocchi began serving as Executive Vice President and Chief Executive Officer of the Company's Patient Direct segment. |
| February 28, 2025 | Company's annual report on Form 10-K filed, containing biographical information for Mr. Bernocchi. |
| December 4, 2025 | Date of earliest event reported; Perry A. Bernocchi appointed Executive Vice President, Chief Operating Officer. |
| December 5, 2025 | Effective date of Perry A. Bernocchi's appointment as Executive Vice President, Chief Operating Officer. |
| December 8, 2025 | Date the 8-K report was signed. |
| December 31, 2025 | Effective date of Jennifer Stone's departure from the Company. |
Recommendation
holdThe filing details routine executive appointments and departures, along with an internal organizational restructuring. While the promotion of an internal COO suggests continuity, the departure of the CHRO and consolidation of HR functions are internal operational adjustments that do not present new material information to warrant a change in investment thesis. The company's core business and financial outlook remain unchanged based on this filing alone, thus a 'hold' recommendation is appropriate.
Keywords
Owens & Minor, OMI, Executive Appointment, Chief Operating Officer, COO, Chief Human Resources Officer, CHRO, Management Change, Corporate Governance, Healthcare Distribution, Medical Supplies
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.